麦肯锡_2025年医疗事业展望A vision for Medical Affairs in 2025.pdf

想预览更多内容，点击预览全文
点击预览本文档（全文）

申明敬告：

本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己完全接受本站规则且自行承担所有风险，本站不退款、不进行额外附加服务；如果您已付费下载过本站文档，您可以点击这里二次下载

文档介绍

Insights into Pharmaceuticals and Medical Products

A vision for

Medical Affairs

in 2025 A vision for Medical Affairs in 2025 As innovation transforms the healthcare landscape, science and data are becoming the foundation for pharma to meet its obligations to patients and customers—and realize commercial opportunities. This imperative is further accelerating the evolution of Medical Affairs as the third strategic pillar of the organization alongside R&D and Commercial. Medical Affairs—a third strategic pillar for the pharmaceutical enterprise Innovation in both digital technology and the biological sciences is advancing at a furious pace, while the quantity of data generated is skyrocketing. Estimates suggest that 2.5 quintillion bytes of data are currently created every day—and the pac

最近下载